荣昌生物：以42.44港元/股的价格成功配发及发行1900万股新H股

Core Viewpoint - Rongchang Biologics (688331.SH) successfully issued a total of 19 million new H-shares at a placement price of HKD 42.44 per share, raising approximately HKD 806.36 million in total proceeds [1] Group 1 - The new H-shares represent about 9.11% of the enlarged total issued H-shares after the placement [1] - The total issued shares after the placement will increase by approximately 3.37% [1] - The net proceeds from the placement, after deducting commissions and estimated expenses, will amount to approximately HKD 796 million [1]